Cargando…
Regulation of ERBB3/HER3 signaling in cancer
ERBB3/HER3 is emerging as a molecular target for various cancers. HER3 is overexpressed and activated in a number of cancer types under the conditions of acquired resistance to other HER family therapeutic interventions such as tyrosine kinase inhibitors and antibody therapies. Regulation of the HER...
Autores principales: | Mujoo, Kalpana, Choi, Byung-Kwon, Huang, Zhao, Zhang, Ningyan, An, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279368/ https://www.ncbi.nlm.nih.gov/pubmed/25400118 |
Ejemplares similares
-
ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells
por: Choi, Byung-Kwon, et al.
Publicado: (2012) -
Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer
por: Zhang, Shu, et al.
Publicado: (2016) -
Crk II silencing down-regulates IGF-IR and inhibits migration and invasion of prostate cancer cells
por: Dhupkar, Pooja, et al.
Publicado: (2016) -
HER3 and LINC00052 interplay promotes tumor growth in breast cancer
por: Salameh, Ahmad, et al.
Publicado: (2016) -
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
por: Shi, Yun, et al.
Publicado: (2014)